A detailed history of Canada Pension Plan Investment Board transactions in Incyte Corp stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 645,889 shares of INCY stock, worth $52.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
645,889
Previous 420,366 53.65%
Holding current value
$52.7 Million
Previous $23.9 Million 63.49%
% of portfolio
0.04%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$51.18 - $63.75 $11.5 Million - $14.4 Million
225,523 Added 53.65%
645,889 $39.2 Million
Q1 2024

May 14, 2024

SELL
$56.55 - $66.59 $2.39 Million - $2.81 Million
-42,273 Reduced 9.14%
420,366 $23.9 Million
Q4 2023

Feb 14, 2024

SELL
$52.16 - $64.19 $657,216 - $808,794
-12,600 Reduced 2.65%
462,639 $29 Million
Q3 2023

Nov 09, 2023

BUY
$57.77 - $65.93 $14.5 Million - $16.6 Million
251,100 Added 112.03%
475,239 $27.5 Million
Q2 2023

Aug 09, 2023

SELL
$60.95 - $75.51 $9.23 Million - $11.4 Million
-151,400 Reduced 40.32%
224,139 $14 Million
Q1 2023

May 12, 2023

BUY
$70.23 - $86.01 $8.53 Million - $10.4 Million
121,447 Added 47.8%
375,539 $27.1 Million
Q4 2022

Feb 14, 2023

SELL
$67.18 - $84.11 $12.5 Million - $15.7 Million
-186,400 Reduced 42.32%
254,092 $20.4 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $2.67 Million - $3.35 Million
40,400 Added 10.1%
440,492 $29.4 Million
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $25.1 Million - $31.5 Million
379,025 Added 1799.14%
400,092 $30.4 Million
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $13.7 Million - $16.5 Million
-206,926 Reduced 90.76%
21,067 $1.67 Million
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $9.95 Million - $11.6 Million
157,123 Added 221.71%
227,993 $16.7 Million
Q3 2021

Nov 15, 2021

SELL
$68.67 - $84.02 $1.14 Million - $1.39 Million
-16,557 Reduced 18.94%
70,870 $4.87 Million
Q2 2021

Aug 16, 2021

SELL
$79.87 - $87.53 $5.73 Million - $6.28 Million
-71,761 Reduced 45.08%
87,427 $7.36 Million
Q1 2021

May 17, 2021

SELL
$76.02 - $100.5 $15.7 Million - $20.8 Million
-206,983 Reduced 56.53%
159,188 $12.9 Million
Q4 2020

Feb 17, 2021

BUY
$80.74 - $97.7 $24.7 Million - $29.9 Million
306,084 Added 509.4%
366,171 $31.9 Million
Q3 2020

Nov 12, 2020

SELL
$85.07 - $109.69 $14.6 Million - $18.9 Million
-171,942 Reduced 74.1%
60,087 $5.39 Million
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $1.36 Million - $2 Million
-18,345 Reduced 7.33%
232,029 $24.1 Million
Q1 2020

May 13, 2020

SELL
$63.18 - $85.97 $4.03 Million - $5.48 Million
-63,751 Reduced 20.29%
250,374 $18.3 Million
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $416,766 - $546,178
-5,706 Reduced 1.78%
314,125 $27.4 Million
Q3 2019

Nov 12, 2019

SELL
$72.82 - $86.52 $30.4 Million - $36.2 Million
-417,961 Reduced 56.65%
319,831 $23.7 Million
Q2 2019

Aug 12, 2019

BUY
$73.52 - $88.7 $4 Million - $4.82 Million
54,382 Added 7.96%
737,792 $62.7 Million
Q1 2019

May 15, 2019

SELL
$63.56 - $88.17 $1.14 Million - $1.58 Million
-17,905 Reduced 2.55%
683,410 $58.8 Million
Q4 2018

Feb 06, 2019

BUY
$58.5 - $69.94 $4.73 Million - $5.66 Million
80,900 Added 13.04%
701,315 $44.6 Million
Q3 2018

Nov 09, 2018

BUY
$61.75 - $74.23 $10.8 Million - $13 Million
175,185 Added 39.35%
620,415 $42.9 Million
Q2 2018

Aug 07, 2018

BUY
$60.85 - $83.98 $13.9 Million - $19.1 Million
227,759 Added 104.73%
445,230 $29.8 Million
Q1 2018

May 14, 2018

BUY
$83.06 - $100.98 $11.7 Million - $14.2 Million
141,100 Added 184.76%
217,471 $18.1 Million
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $3.19 Million - $3.97 Million
-34,044 Reduced 30.83%
76,371 $7.23 Million
Q3 2017

Oct 30, 2017

BUY
$109.15 - $138.27 $4.03 Million - $5.1 Million
36,900 Added 50.19%
110,415 $12.9 Million
Q2 2017

Jan 31, 2018

SELL
N/A
-484,196 Reduced 86.82%
73,515 $9.26 Million
Q1 2017

Jan 31, 2018

BUY
N/A
557,711
557,711 $74.5 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.